A Study to Assess the Safety and Tolerability of E2511 in Healthy Participants

NCT04547361 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: E2511
DRUG: E2511 Matched Placebo

Sponsor

Eisai Inc.